Susquehanna Portfolio Strategies
Susquehanna Portfolio Strategies reported 729 stocks worth $5.2B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are PM (1.8%), MRNA (1.7%) and MDT (1.7%). Compared with Q2 2026, the fund opened new positions in CEG, FOXA and TMO, added to PM, MDT and WMT, trimmed EQIX, TMUS and PLD and sold out of INTC, TJX and CNC.
Latest filing: what Susquehanna Portfolio Strategies did in Q3 2026
vs Q2 2026Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() PM Philip Morris Intl Inc | $96.3M | 1.8% | 505K | +101K (+25%) | 5 of 8 | |
| 2 | ![]() MRNA Moderna Inc | $90.7M | 1.7% | 471K | No change | 5 of 8 | |
| 3 | ![]() MDT Medtronic PLC F | $87.5M | 1.7% | 1M | +57K (+6%) | 3 of 8 | |
| 4 | ![]() ABBV Abbvie Inc | $87.1M | 1.7% | 333K | No change | 3 of 8 | |
| 5 | ![]() WMT Walmart Inc | $72.8M | 1.4% | 700K | +584K (+504%) | 2 of 8 | |
| 6 | ![]() HUM Humana Inc | $69.4M | 1.3% | 182K | +5,860 (+3%) | 6 of 8 | |
| 7 | ![]() CI The Cigna Group | $69.1M | 1.3% | 254K | +18K (+8%) | 5 of 8 | |
| 8 | ![]() AMGN Amgen Inc | $64.7M | 1.2% | 154K | +2,240 (+1%) | 5 of 8 | |
| 9 | ![]() MNST Monster Beverage Corp New | $64.6M | 1.2% | 1.6M | +193K (+14%) | 6 of 8 | |
| 10 | ![]() CL Colgate Palmolive Co | $62.2M | 1.2% | 729K | +69K (+10%) | 2 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
![]() INTC Intel Corp | $146M | 1M |
![]() TJX Tjx Cos Inc New | $62M | 409K |
![]() CNC Centene Corp Del | $54.5M | 849K |
![]() CMI Cummins Inc | $44.4M | 62K |
ELECTRONIC ARTS INC | $36.3M | 177K |
🔒 Free account: see all 30.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 16, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Susquehanna Portfolio Strategies 13F FAQ
What does Susquehanna Portfolio Strategies own?
Susquehanna Portfolio Strategies reported 729 stocks worth $5.2B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are PM (1.8%), MRNA (1.7%) and MDT (1.7%). The table above lists every position in the filing (the top 10 without an account).
What did Susquehanna Portfolio Strategies buy and sell in Q3 2026?
Compared with Q2 2026: 130 new positions, 214 added to, 304 trimmed and 234 sold out. New positions include CEG, FOXA and TMO. It sold all of INTC, TJX and CNC.
When will Susquehanna Portfolio Strategies file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is Susquehanna Portfolio Strategies's portfolio worth?
The Q3 2026 filing reports $5.2B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.



























